Effectiveness of Casirivimab-Imdevimab and Sotrovimab Monoclonal Antibody Treatment among High-Risk Patients with Sars-Cov-2 Infection: A Real-World Experience. (2023). Archives of Clinical and Biomedical Research, 7(3), 325-336. https://fortunejournals.org/ojs/index.php/acbr/article/view/15015